February 2013
Table of Contents
|
|
Shared Resource Spotlight
Flow Cytometry Core
The FC Core provides
investigators with a wide
range of services related to
cell sorting and analysis.
Coming soon!
The FC Core will have an
Amnis ImageStream Mark II.
This system can produce
60,000 images of 10,000
cells in about 30 seconds
and 600,000 images of
100,000 cells in just over
5 minutes. The system utilizes the IDEAS® data analysis software that currently calculates over
40 quantitative features per image, resulting in approx. 250 features per cell.
These features can be used to generate histograms and
scatter plots, much like
Co-Directors:
Daniel Conrad, Ph.D.,
and Julie Farnsworth
Contact Information:
(804) 828-2311
View more information
about the FC Core.
|
Connect with us!
Join Massey's online communities.
   |
|
 |
|
Leaders' Update
Interim associate director for clinical research
I am pleased to update you on clinical research at Massey. We've made progress on several fronts...
This message continues with more information about:
|
Research Highlights
|
 |
Cancer Cell Signaling
co-leader |
Multiple sclerosis drug may one day treat colorectal cancer
Fingolimod, a drug currently approved for the treatment of multiple sclerosis, has been found to potentially eliminate or reduce the progression of colorectal cancer.
|
Viagra drug trio improves effectiveness of cancer treatment while protecting the heart
A new drug 'trifecta' combining doxorubicin, Viagra and rapamycin has been found to improve the effectiveness of cancer treatment while protecting the heart from harm caused by a popular form of chemotherapy.
|
Reasons patients are ineligible or refuse to participate in clinical trials
The reasons why Caucasian and African-American patients who are offered a clinical trial are ineligible or refuse to participate differ.
|
Center News
|
This year, the VCU Presidential Symposium led by Michael Rao, Ph.D., will focus on cancer.
Dr. Rao has asked Massey to help develop the symposium.
Dr. Lowy's laboratory was involved in the initial development, characterization and clinical testing of preventive virus-like particles that are now used in two FDA-approved HPV vaccines.
The symposium will likely occur in late September or October. Stay tuned for more information.
|
Member Showcase
Massey welcome
as one of the newest research members in the Cancer and Molecular Genetics program.
Miles is also a professor of pharmacology and toxicology at the VCU School of Medicine. His cancer research focuses on understanding the molecular mechanisms of alcohol and tobacco addiction and how they modulate cancer risk.
|
Researcher Recognition
|
Congratulations to the following Massey pilot grant award winners:
|
|
|
